| Product Code: ETC10765570 | Publication Date: Apr 2025 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
The Belgian import market for pemetrexed experienced a shift in concentration from low to moderate in 2024, with top exporting countries including Italy, Germany, USA, Metropolitan France, and Switzerland. Despite a slight decline in growth rate from 2023 to 2024, the compound annual growth rate (CAGR) over the 2020-2024 period remained strong at 6.48%. This indicates a stable demand for pemetrexed in Belgium, with key suppliers continuing to play a significant role in supplying this pharmaceutical product to the market.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Belgium Pemetrexed Market Overview |
3.1 Belgium Country Macro Economic Indicators |
3.2 Belgium Pemetrexed Market Revenues & Volume, 2021 & 2031F |
3.3 Belgium Pemetrexed Market - Industry Life Cycle |
3.4 Belgium Pemetrexed Market - Porter's Five Forces |
3.5 Belgium Pemetrexed Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Belgium Pemetrexed Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Belgium Pemetrexed Market Revenues & Volume Share, By Combination Therapy, 2021 & 2031F |
3.8 Belgium Pemetrexed Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Belgium Pemetrexed Market Revenues & Volume Share, By Administration Route, 2021 & 2031F |
4 Belgium Pemetrexed Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Belgium Pemetrexed Market Trends |
6 Belgium Pemetrexed Market, By Types |
6.1 Belgium Pemetrexed Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Belgium Pemetrexed Market Revenues & Volume, By Indication, 2021 - 2031F |
6.1.3 Belgium Pemetrexed Market Revenues & Volume, By Non-Small Cell Lung Cancer, 2021 - 2031F |
6.1.4 Belgium Pemetrexed Market Revenues & Volume, By Mesothelioma, 2021 - 2031F |
6.1.5 Belgium Pemetrexed Market Revenues & Volume, By Breast Cancer, 2021 - 2031F |
6.1.6 Belgium Pemetrexed Market Revenues & Volume, By Colorectal Cancer, 2021 - 2031F |
6.1.7 Belgium Pemetrexed Market Revenues & Volume, By Pancreatic Cancer, 2021 - 2031F |
6.2 Belgium Pemetrexed Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Belgium Pemetrexed Market Revenues & Volume, By Antifolate, 2021 - 2031F |
6.2.3 Belgium Pemetrexed Market Revenues & Volume, By DNA Synthesis Inhibition, 2021 - 2031F |
6.2.4 Belgium Pemetrexed Market Revenues & Volume, By Enzyme Targeting, 2021 - 2031F |
6.2.5 Belgium Pemetrexed Market Revenues & Volume, By Cell Growth Suppression, 2021 - 2031F |
6.2.6 Belgium Pemetrexed Market Revenues & Volume, By Purine Synthesis Blockade, 2021 - 2031F |
6.3 Belgium Pemetrexed Market, By Combination Therapy |
6.3.1 Overview and Analysis |
6.3.2 Belgium Pemetrexed Market Revenues & Volume, By Platinum-Based Chemotherapy, 2021 - 2031F |
6.3.3 Belgium Pemetrexed Market Revenues & Volume, By Immunotherapy, 2021 - 2031F |
6.3.4 Belgium Pemetrexed Market Revenues & Volume, By Radiation Therapy, 2021 - 2031F |
6.3.5 Belgium Pemetrexed Market Revenues & Volume, By Personalized Medicine, 2021 - 2031F |
6.3.6 Belgium Pemetrexed Market Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031F |
6.4 Belgium Pemetrexed Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 Belgium Pemetrexed Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.4.3 Belgium Pemetrexed Market Revenues & Volume, By Oncology Clinics, 2021 - 2031F |
6.4.4 Belgium Pemetrexed Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.5 Belgium Pemetrexed Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.4.6 Belgium Pemetrexed Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.5 Belgium Pemetrexed Market, By Administration Route |
6.5.1 Overview and Analysis |
6.5.2 Belgium Pemetrexed Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.5.3 Belgium Pemetrexed Market Revenues & Volume, By Injection, 2021 - 2031F |
6.5.4 Belgium Pemetrexed Market Revenues & Volume, By IV Infusion, 2021 - 2031F |
6.5.5 Belgium Pemetrexed Market Revenues & Volume, By Cancer Treatment Centers, 2021 - 2031F |
6.5.6 Belgium Pemetrexed Market Revenues & Volume, By Hospital Pharmacy, 2021 - 2031F |
7 Belgium Pemetrexed Market Import-Export Trade Statistics |
7.1 Belgium Pemetrexed Market Export to Major Countries |
7.2 Belgium Pemetrexed Market Imports from Major Countries |
8 Belgium Pemetrexed Market Key Performance Indicators |
9 Belgium Pemetrexed Market - Opportunity Assessment |
9.1 Belgium Pemetrexed Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Belgium Pemetrexed Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Belgium Pemetrexed Market Opportunity Assessment, By Combination Therapy, 2021 & 2031F |
9.4 Belgium Pemetrexed Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 Belgium Pemetrexed Market Opportunity Assessment, By Administration Route, 2021 & 2031F |
10 Belgium Pemetrexed Market - Competitive Landscape |
10.1 Belgium Pemetrexed Market Revenue Share, By Companies, 2024 |
10.2 Belgium Pemetrexed Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here